Table 3. The characteristics of included PTC patients (TCGA dataset, N = 449).
Pathological parameters | No. of patients N (%) | |
---|---|---|
Age | < 45 | 198 (45.3) |
≥ 45 | 239 (54.7) | |
Gender | Male | 122 (27.9) |
Female | 315 (72.1) | |
Tumor subtypes | Classical/Usual | 310 (70.9) |
Tall cell | 33 (7.6) | |
Follicular | 89 (20.4) | |
Others | 5 (1.1) | |
History of other tumor | No | 406 (94.2) |
Yes | 25 (5.8) | |
Pathological stage | I–II | 285 (65.5) |
III–IV | 150 (34.5) | |
T stage | T1–T2 | 264 (60.4) |
T3–T4 | 173 (39.6) | |
N stage | Nx–N0 | 236 (54.0) |
N1 | 201 (46.0) | |
M stage | M0 | 428 (98.2) |
M1 | 8 (1.8) | |
Focus types | Unifocal | 228 (53.3) |
Multifocal | 200 (46.7) | |
Extrathyroidal extension | No | 280 (66.2) |
Yes | 143 (33.8) | |
BRAFV600E | Mutation type | 212 (48.5) |
Wild type | 225 (51.5) |